Analyst David Low works at JPMORGAN and is focused on the Healthcare sector with 25 price targets and ratings documented since 2013 spanning on 1 stocks. Previously, David Low worked at DEUTSCHE BANK. Analyst's average stock valuation to be materialised ratio is 80% with an average time for price targets to be met of 161 days.
Most recent stock forecast was given on RMD, ResMed Inc at 12-Aug-2022.
David Low best performing recommendations are on RMD (RESMED INC).
The best stock recommendation documented was for RMD (RESMED INC) at 5/21/2021. The price target of $219 was fulfilled within 24 days with a profit of $19.05 (9.53%) receiving and performance score of 3.97.
Average potential price target upside